Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aytu BioScience Inc (AYTU)
NASDAQ:AYTU
Holding AYTU?
Track your performance easily
AYTU Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.53 - $3.50
Previous Close$2.4
Volume9.74K
Average Volume (3M)17.20K
Market Cap
$14.75M
Enterprise Value$11.29M
Total Cash (Recent Filing)$19.76M
Total Debt (Recent Filing)$16.72M
Price to Earnings (P/E)―
Beta1.16
Next Earnings
Sep 25, 2024EPS Estimate
-$0.45Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.63
Shares Outstanding5,970,000
10 Day Avg. Volume8,499
30 Day Avg. Volume17,198
Standard Deviation0.31
R-Squared0.06
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)0.47
Price to Sales (P/S)0.16
Price to Cash Flow (P/CF)-12.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.12
Enterprise Value/Gross Profit0.17
Enterprise Value/Ebitda12.09
Forecast
1Y Price Target
$8.00Price Target Upside233.33% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Aytu BioScience News
PremiumCompany Announcements
Aytu BioScience Divests Consumer Health Business
PremiumCompany Announcements
Aytu BioScience Bolsters Growth with Strategic Financial Moves
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AYTU FAQ
What was Aytu BioScience Inc’s price range in the past 12 months?
Aytu BioScience Inc lowest stock price was $1.52 and its highest was $3.50 in the past 12 months.
What is Aytu BioScience Inc’s market cap?
Currently, no data Available
When is Aytu BioScience Inc’s upcoming earnings report date?
Aytu BioScience Inc’s upcoming earnings report date is Sep 25, 2024 which is in 5 days.
How were Aytu BioScience Inc’s earnings last quarter?
Aytu BioScience Inc released its earnings results on May 15, 2024. The company reported -$0.52 earnings per share for the quarter, beating the consensus estimate of -$0.64 by $0.12.
Is Aytu BioScience Inc overvalued?
According to Wall Street analysts Aytu BioScience Inc’s price is currently Undervalued.
Does Aytu BioScience Inc pay dividends?
Aytu BioScience Inc does not currently pay dividends.
What is Aytu BioScience Inc’s EPS estimate?
Aytu BioScience Inc’s EPS estimate is -$0.45.
How many shares outstanding does Aytu BioScience Inc have?
Aytu BioScience Inc has 5,972,327 shares outstanding.
What happened to Aytu BioScience Inc’s price movement after its last earnings report?
Aytu BioScience Inc reported an EPS of -$0.52 in its last earnings report, beating expectations of -$0.64. Following the earnings report the stock price went down -3.268%.
Which hedge fund is a major shareholder of Aytu BioScience Inc?
Currently, no hedge funds are holding shares in AYTU
---
Aytu BioScience Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.00 (233.33% Upside)
$8.00 (233.33% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 4.9%
Last 30 Days ▼ 4.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
50.60%
12-Months-Change
Fundamentals
Return on Equity
-38.18%
Trailing 12-Months
Asset Growth
-12.47%
Trailing 12-Months
Company Description
Aytu BioScience Inc
Aytu BioScience, Inc. is a specialty pharmaceutical company, which focuses on identifying, acquiring, and commercializing novel products. Its products include Natesto, Tuzistram, ZolpiMist and MiOXSYS. The company was founded on August 9, 2002 and is headquartered in Englewood, CO.
---
AYTU Earnings Call
Q3 2024
0:00 / 0:00
---
AYTU Stock 12 Month Forecast
Average Price Target
$8.00
▲(233.33% Upside)
Technical Analysis
Brainstorm Cell Therapeutics
―
Citius Pharmaceuticals
―
Cyclacel Pharmaceuticals
―
Daré Bioscience
―
Best Analysts Covering AYTU
1 Year
1 Year Success Rate
3/8 ratings generated profit
1 Year Average Return
-1.45%
reiterated a buy rating last month
Copying Naz Rahman's trades and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of -1.45% per trade.
---